Tag: cannabis

  • CBD and Cannabis Products for Acne, Psoriasis? Buyer Beware, Dermatologists Say | Health News

    CBD and Cannabis Products for Acne, Psoriasis? Buyer Beware, Dermatologists Say | Health News

    By Denise Mann HealthDay Reporter

    (HealthDay)

    MONDAY, Jan. 17, 2022 (HealthDay Information) — Growing quantities of folks are turning to CBD or cannabis products to treat skin disorders like acne or rosacea, but scientists warn that the science on their protection and power has not stored up with desire.

    When additional than 500 older people have been questioned about their use of CBD (cannabidiol) or cannabis, absolutely 17.6{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} explained they employed an around-the-counter hashish product or service to address skin situations this sort of as zits, psoriasis, rosacea or eczema without having a suggestion from a skin doctor, and even far more people have been fascinated in seeking these products.

    CBD is derived from hemp, a cousin of the cannabis plant, but in contrast to THC (delta-9-tetrahydrocannabinol), the lively ingredient in marijuana, CBD won’t get you significant.

    “People today are making use of these solutions with out the route of a medical professional, and even these who weren’t working with them are fascinated in understanding much more,” claimed examine creator Dr. Adam Friedman, chair of dermatology at the George Washington College of Medicine and Health Sciences in Washington, D.C.

    It’s time for science to catch up, he explained.

    There are some promising early animal facts that indicates how these merchandise may possibly support address inflammatory skin diseases. “We know that cannabinoids activate the body’s resolvin pathway, which resolves swelling,” reported Friedman. “Cannabinoids set the phase for irritation to resolve and recruit the players that are important to cleansing up the damage from inflammation.”

    About 89{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of people reported there is a purpose for cannabis or other hashish products in the procedure of pores and skin disease, and the majority mentioned they would be ready to check out one of these products if they bought a inexperienced light from their dermatologist.

    Of the two-thirds of people today who experienced viewed a dermatologist, 20{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} were being told to try a CBD solution, generally for acne and psoriasis. Just shy of 8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of these people employed clinical hashish, which requires an authorised card from a dermatologist.

    However, it truly is customer beware when it comes to CBD, as these solutions are not controlled by the U.S. Food stuff and Drug Administration in the exact same way as drugs, Friedman reported. Clinical marijuana involves a physician-issued prescription card and can only be purchased from condition-run dispensaries so there is more high-quality regulate, he added.

    So, how can you determine out if the products you pick is any superior?

    Constantly critique the CBD product’s Certificate of Examination (COA). This document offers effects of any screening of the nutritional supplements, and corporations can release it voluntarily, Friedman reported. “If it is not on the net, achieve out to the business, and if they will not share it, that is a crimson flag,” he mentioned.

    Glimpse at the other ingredients, way too, he claimed, mainly because “if you have sensitivity to other actives, you could respond.”

    And in no way use these products in area of prescribed remedies for your pores and skin condition, Friedman stressed.

    Other specialists not associated with the study point out you can find continue to a ton to study about the job of CBD and healthcare marijuana in pores and skin and other ailments.

    “Every thing from the accurate ingredient CBD or THC, the appropriate dose and the suitable formulation nevertheless genuinely wants to be hammered out,” reported Dr. Peter Lio, a clinical assistant professor of dermatology and pediatrics at Northwestern College Feinberg Faculty of Medication in Chicago.

    “There is some evidence that topical CBD goods can have anti-itch, anti-inflammatory, and even wound-healing properties in skin condition,” he mentioned. “These also seem pretty safe and sound and do not have the similar challenges as solutions that contain THC, which is the psychoactive element of the marijuana plant.”

    Normally do a patch examination, Lio pressured: “Any new product or service could most likely cause issues, primarily in those people with additional delicate skin.”

    It tends to make feeling that men and women are turning toward these solutions, explained Dr. Mark Moyad. He is the Jenkins/Pokempner Director of Preventive and Choice Medication at the College of Michigan Health-related Heart in Ann Arbor.

    “Unfilled, unmet or unhappy desires and expectations of some of the conventional solutions may drive individuals to try CBD or health care cannabis for skin problems,” Moyad defined.

    Regrettably, drug interactions and challenges are remaining uncovered on the fly, he noted.

    “These merchandise are in this article to keep and folks need responses, which suggests additional funding should really be focused to objective research simply because we require to find out where these merchandise may be really handy,” Moyad mentioned.

    Resources: Adam Friedman, MD, professor and chair, dermatology, George Washington Faculty of Drugs and Wellness Sciences, Washington, D.C. Peter Lio, MD, medical assistant professor, dermatology and pediatrics, Northwestern University Feinberg University of Medicine, Chicago Mark Moyad, MD, MPH, Jenkins/Pokempner Director of Preventive and Substitute Drugs, University of Michigan Clinical Centre, Ann Arbor Journal of Drugs in Dermatology, January 2022

    Copyright © 2022 HealthDay. All rights reserved.

  • Cannabis Use May Cause Cognitive Impairments

    Cannabis Use May Cause Cognitive Impairments

    A person holds an unrolled cannabis cigaretteShare on Pinterest
    Researchers have issued a warning about hashish use as the drug gets to be legal in far more locations.
    Matteo Guedia/Getty Illustrations or photos
    • In a new analyze, researchers say hashish users can have cognitive impairments beyond the original use period.
    • The cognitive impairments can influence choice creating, memory, and the means to comprehensive mental duties.
    • Some professionals say the investigation is flawed simply because it doesn’t acquire into account the diverse varieties of hashish and the unique ways it can be ingested.
    • Some gurus who deal with cannabis-similar conditions say they have observed the outcomes of the drug’s use, particularly in more youthful men and women whose brains are even now producing.

    Folks making use of cannabis can have acute cognitive impairments long lasting past the interval of intoxication, in accordance to a review led by Canadian scientists that was released now.

    The researchers say it is significant for end users to realize these lengthy-phrase results as cannabis legalization gets to be additional popular.

    The researchers looked at the results of hashish on far more than 43,000 individuals.

    They reported that hashish causes tiny to average cognitive impairments in parts that effects decision making, suppressing inappropriate responses, finding out, and remembering through listening and examining as perfectly as how a lot time an individual desires to full psychological tasks.

    The examine implies that the damaging overall health outcomes of hashish, which commence through consumption, can past for a considerable total of time.

    “Our examine enabled us to highlight quite a few locations of cognition impaired by cannabis use, which includes challenges concentrating and issues remembering and discovering, which may well have sizeable influence on users’ daily life,” wrote Dr. Alexandre Dumais, an associate medical professor of psychiatry at Université de Montréal and a examine co-author.

    “Cannabis use in youth may as a result guide to lowered instructional attainment, and, in grownups, to very poor do the job efficiency and harmful driving. These penalties may well be even worse in common and significant users,” he said.

    The researchers issued a warning about growing acceptability of cannabis remaining “on the increase,” especially among youthful folks, who have the best rates of use.

    “It is hence essential to fully grasp the cognitive threats included in employing hashish, especially to young persons, whose brains are undergoing sizeable developmental variations,” the study authors wrote.

    Industry experts disagree on the extent of the damaging outcomes brought on by cannabis. Research into cannabis’ outcomes has been rather minimal, because of to it being unlawful and not obtainable for several analysis assignments.

    “Marijuana can be destructive to the mind and it can also be handy for clinical reasons. The truth is that there is just not adequate investigate to know a precise remedy,” claimed Dr. Rebecca Siegel, a New York Metropolis medical psychiatrist and writer of “The Brain on Cannabis: What You Must Know About Leisure and Healthcare Cannabis.”

    “We do know that cannabis use can effect the brain’s frontal lobe which controls executive performing — selection making, problem-solving, and many others.,” Siegel instructed Healthline. “Because THC impacts the hippocampus and prefrontal cortex, cannabis people may well encounter problems with concentration and memory. But with no those people scientific studies, we simply cannot know for sure and we will not know till more uniform, controlled reports are performed.

    “We do know that the brains of younger adults are continuing to sort until their mid-20s, so cannabis use in that population requirements to be thoroughly managed and monitored by a physician,” she mentioned.

    Michele Ross has a PhD in neuroscience and has examined the effects of hashish on the mind for the Countrywide Institute on Drug Abuse.

    She told Healthline the examine is flawed for the reason that of its limits and that it ignores millions of successful people all over the entire world who consistently use hashish.

    “The experiments most likely do not search at hashish consumed in other techniques, including hashish tinctures, cannabis edibles, and so forth., which never expose the user to hazardous effects of smoke, which induce memory issues themselves,” Ross explained. “They also do not appear at cigarette smoking hashish that involves each THC and CBD, which has been proven to reduce any prospective non permanent harms of using tobacco superior-THC cannabis strains.”

    Dr. Adam D. Scioli, professional medical director and head of psychiatry at Caron Cure Facilities, explained to Healthline the way hashish is consumed does not matter when it will come to its possible problems.

    “It does not make a difference how you consider cannabis because the long-term intoxicating and impairing effects are similar,” Scioli said. “Factors that could affect impairment consist of the concentration of THC in the cannabis, quantity, frequency, and duration of publicity.

    “Genetics, as properly as underlying clinical and mental wellbeing conditions, also add to the severity of cognitive impairment in people today uncovered to hashish,” he said.

    Scioli stated he sees firsthand affirmation of the study’s conclusions.

    “The results ensure what we’ve found empirically by means of psychometric tests in adolescent and grownup clients at Caron who struggle with cannabis use problems,” Scioli stated. “We see reasonable to extreme impairment in government working that is consistent with the cognitive impairment documented in this study.

    Scioli stated there’s no uncomplicated way to erase the adverse consequences of hashish.

    “The greatest method is not to use cannabis or look for assist if you’re using and struggling to end on your very own,” he mentioned. “Oftentimes with cessation, we notice gradual enhancement in cognitive purpose. But that’s not always the case. This analysis is vital since it functions as a cautionary tale and highlights the have to have to gradual down and greater have an understanding of the very long-time period implications of hashish use instead of producing it a magic elixir to deal with every little thing.”

  • MS lawmakers defy gov’s medical cannabis demands (Newsletter: January 13, 2022)

    MS lawmakers defy gov’s medical cannabis demands (Newsletter: January 13, 2022)

    KY medical cannabis bill filed; MS senator brings hemp to marijuana meeting with gov; CA spends $100M on marijuana cannabis grants for cities

    Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.

    Your support makes Marijuana Moment possible…

    Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. 

    • Matt W.: “I pledged because I value the news and information you provide and want to see it continue.”

    If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment

    / TOP THINGS TO KNOW

    Anti-drug Sen. Charles Grassley (R-IA) has been helping an Iowa church that wants to incorporate the psychedelic brew ayahuasca into its ceremonies—the Iowaska Church of Healing—with legal fights against the Drug Enforcement Administration and the Internal Revenue Service.

    A Kentucky Republican representative filed a medical marijuana bill that’s been revised from past versions in an attempt to win support—or at least remove hostile opposition—from legislative leaders so that it can pass this year.

    A Mississippi senator brought hemp to a meeting with Gov. Tate Reeves (R) to help assuage the governor’s concerns about medical marijuana possession limits.

    • “I took samples to show him what an ounce actually looks like—what 3.5 grams actually looks like.”

    California regulators awarded $100 million in funding to help local governments develop the legal marijuana market by processing business licenses.

    / FEDERAL

    A federal judge dismissed a Washington State marijuana dispensary’s racial discrimination lawsuit against state and federal officials.

    Rep. Dave Joyce (R-OH) criticized Democratic leaders for not advancing cannabis reform legislation.

    Rep. Nancy Mace (R-SC) authored a Wall Street Journal letter to the editor about her marijuana legalization bill.

    Florida Democratic Senate candidate Allen Ellison tweeted, “Not only should we legalize cannabis across the country, we should tax the sale of it and pay for higher education.”

    Kentucky Democratic congressional candidate William Compton tweeted, “Along with the revenue we can generate by legalizing Marijuana, we should not have someone go to jail for Marijuana. In congress, I will fight to legalize Marijuana nationwide.”

    / STATES

    Rhode Island’s House speaker said a new marijuana legalization bill should be released in the next 30-45 days.

    New Jersey’s Senate president said he doesn’t think home cultivation of marijuana will be legalized “any time soon.”

    South Carolina’s Senate majority leader indicated a medical cannabis bill will be considered soon, saying, “I don’t know where the votes will be, but we all agree it’s time to have a debate and move on.” And another senator said he expects the legislation to be one of the first brought up in the new session.

    The Wisconsin House State Affairs Committee approved a kratom regulation bill.

    Mississippi lawmakers are expected to consider a medical cannabis bill this week. One senator wants pharmacists to be involved in distributing marijuana.

    The Virginia legislature’s Cannabis Oversight Commission will meet on Monday.

    Kansas House Democrats tweeted, “House Democrats want Kansans like YOU to decide if Kansas should expand Medicaid and legalize marijuana. Contact your #ksleg-legislator TODAY and tell them you want to vote on issues that affect your life and your health.”

    A Florida senator filed a marijuana legalization bill and companion tax legislation.

    An Indiana representative filed a medical cannabis bill.

    A Maryland senator tweeted, “Legalizing marijuana is not about easing access to personal indulgence, it’s about creating equality.”

    The Illinois Supreme Court is being asked by a marijuana business to let regulators name the winners of new craft grower licenses.

    New York regulators filed proposed cannabinoid hemp rules. Separately, the Department of Agriculture and Markets is seeking certified hemp sampling agents.

    The Utah Peace Officer Standards & Training Council voted to make it so cadets applying to be emergency dispatchers will not have to undergo a waiting period if they’ve used marijuana in a place where it’s legal.

    Ohio regulators received nine petitions to add new medical cannabis qualifying conditions.

    Oregon regulators are conducting a survey on interest in accessing psilocybin services and related issues.

    Vermont regulators will consider marijuana issues on Monday.

    The Washington State Cannabis Science Task Force will meet on Monday.


    Marijuana Moment is already tracking more than 900 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

    Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.

    / LOCAL

    The Kent, Ohio City Council is moving to place a marijuana decriminalization measure on the November ballot.

    Long Beach, California’s mayor tweeted, “In Long Beach we legalized cannabis before the state. We created a regulatory framework and taxed products and production. It’s time to legalize weed across the country.”

    Oakland, California officials will discuss loan and grant programs for cannabis equity businesses on Tuesday.

    / INTERNATIONAL

    Appointments for first-dose COVID vaccinations in Quebec, Canada spiked after the government announced the shots would be required to enter marijuana dispensaries and liquor stores.

    The Australian government is funding clinical trials on psilocybin, CBD, DMT and MDMA-assisted psychotherapy to treat debilitating mental illness.

    / SCIENCE & HEALTH

    A study found that “t​​wo years after legalization in Canada, the price of dried flower from legal sources decreased, along with a greater percentage of consumers purchasing from legal sources than after one year.”

    A study suggested that “MDMA/ecstasy and psilocybin use is associated with lower risk of depression.”

    / ADVOCACY, OPINION & ANALYSIS

    The American Medical Association said expanding medical marijuana research will be a topic of discussion at its conference next month.

    The Kentucky Democratic Party tweeted, “Democrats are heading to work every day this session committed to fighting for you. Health care, voting rights, universal pre-K, medical marijuana and much more: @GovAndyBeshear, @KYSenateDems and @KYHouseDems are prioritizing the issues Kentuckians care about.”

    / BUSINESS

    Columbia Care Inc. is commencing a solicitation of consents from noteholders.

    Ayr Wellness sent an update on its stock repurchase program.

    Swade Cannabis workers in St Louis, Missouri are seeking to organize a union.

    / CULTURE

    Filmmaker Kevin Smith posted about running into his daughter at a marijuana dispensary.

    Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.

    Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

  • Can Cannabis Help With ADHD? Benefits vs. Risks

    Can Cannabis Help With ADHD? Benefits vs. Risks

    Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental condition that affects 11{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of school-aged children and an estimated 4.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of adults.

    ADHD is characterized by an inability to sit still, trouble focusing, and impulsive behavior. Because cannabis (Cannabis sativa) has been linked to relaxation, many people are curious whether the medicinal herb can be helpful in managing ADHD symptoms.

    The research on whether cannabis can provide short-term relief of hyperactivity in people with ADHD is mixed. And researchers are still trying to learn more about cannabis and ADHD. Here’s what you should know about the effects of cannabis on people with ADHD. 

    Sharon Mccutcheon / EyeEm / Getty Images


    How Cannabis Could Help With ADHD Symptoms 

    To understand how cannabis might provide relief for ADHD symptoms, it’s important to understand the two components of cannabis, which are:

    • Tetrahydrocannabinol (THC): THC is a psychoactive component that gives the “high” associated with cannabis. It acts on the areas of the brain that control focus, coordination, and reaction time.
    • Cannabidiol (CBD): CBD is a nonpsychoactive component in cannabis and hemp (a type of cannabis plant that contains 0.3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} or less THC). It acts on different areas of the brain and can counteract the effects of THC. CBD has been shown to help regulate brain activity.

    When you smoke or consume cannabis, you take in both THC and CBD. 

    Cannabis for ADHD: What Research Says

    There isn’t much research on using cannabis for ADHD because federal research on cannabis has been restricted by the drug’s schedule 1 status (drugs not currently accepted for medical use that have a potential for abuse). However, the research that is available gives a mixed answer to the question of can cannabis help with ADHD, including: 

    • A small 2020 study of 112 adult patients with ADHD who used medical cannabis found that those who took a higher dose of medical cannabis components, like CBD, took fewer other ADHD medications.
    • A 2019 medical review of 83 studies found that there was “scant” and “insufficient” evidence on the effectiveness of cannabis to treat mental health conditions, including ADHD.
    • A 2021 study of 1,700 students found that those with ADHD self-reported that using cannabis improved their ADHD symptoms and lessened their side effects from their ADHD medication.
    • A 2016 study that analyzed online posts mentioning cannabis and ADHD found that 25{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of those posts stated a positive impact of cannabis on ADHD symptoms, as opposed to 8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} that said it was harmful.

    More research is needed to determine if cannabis can have benefits for adults with ADHD. However, at this time, most states with medical cannabis programs do not include ADHD as a qualifying condition for getting a license. 

    Cannabis and Kids

    Although ADHD is most often diagnosed in children, cannabis should not be used by most young people. Even states with recreational cannabis laws don’t allow people under 21 years old to purchase or consume cannabis. Medical cannabis programs for children are extremely limited, and ADHD is not a qualifying condition. 

    Using Cannabis With ADHD Medications 

    There’s limited research on how cannabis interacts with ADHD medications, such as Adderall (dextroamphetamineamphetamine). A small 2015 study of adults without ADHD found that when Adderall and marijuana were taken together, they produced unique effects (neither positive nor negative) compared with either medication taken alone.

    If you’re on ADHD medications, it’s important that you be upfront and honest with your healthcare provider about your cannabis use. Cannabis use is becoming mainstream and is legal in some places. Your healthcare provider can help you understand the benefits and risks of using cannabis with ADHD medications. 

    Cannabis Effects by Strain Type 

    Some people believe that different strains of cannabis produce different effects. Strains are different varieties of the cannabis plant. Common marketing distinguishes between these two strains:

    • Sativa is believed to energize.
    • Indica is believed to have calming and pain-reducing effects.

    However, research shows the differences between strains are not necessarily accurate. The effects of cannabis are dictated by its levels of THC and CBD, with each having different effects on the brain and body. Most Indica strains are thought to have a higher proportion of CBD, which lends them their calming effects.

    Most research in favor of cannabis for ADHD shows benefits of CBD, so you may want to choose a cannabis strain with a higher proportion of CBD (such as an Indica product) or try CBD oil (or other CBD-only product) instead of cannabis. 

    When Does Cannabis Use Become a Substance Use Disorder?

    About 30{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of people who use cannabis will develop a substance use disorder. A substance use disorder occurs when substance use begins to interfere with a person’s day-to-day functioning.

    Research shows that CBD alone, without THC, is not addictive. So, if you are concerned about developing a substance use disorder, you may want to choose a product with only CBD as opposed to both CBD and THC. 

    Summary

    There’s little research on whether cannabis can help with ADHD. The research that exists is mixed: Some studies have found that cannabis can help with ADHD symptoms, while others conclude there is insufficient evidence to make that conclusion.

    In most cases, ADHD doesn’t qualify for state medical cannabis programs, and cannabis should never be used to treat ADHD in people under age 21. It’s best to have an open and honest conversation with your healthcare provider about using cannabis if you have ADHD. 

    A Word From Verywell

    It’s normal to wonder whether cannabis can treat your ADHD symptoms. Unfortunately, there’s no clear answer. Luckily, researchers are continuing to explore the medical potential of cannabis. Hopefully, within a few years, we’ll have a better idea of the impact of marijuana on people with ADHD. 

    Frequently Asked Questions

    • Should you talk to your doctor before you stop taking prescribed ADHD medicine?

      Yes, you should always talk with your healthcare provider before stopping ADHD medications. Sometimes finding the right medications for ADHD can take time. Rather than stopping your medications, reach out to your medical provider to discuss your concerns. 

    • How much cannabis is too much?

      If your cannabis use is interfering with your day-to-day functioning, it’s time to seek help. Remember that even in states with recreational cannabis programs, cannabis is illegal for people who are under the age of 21. 

    • What the best type of cannabis for ADHD?

      There’s little research about the effects of different forms of cannabis for people with ADHD. However, CBD seems to show more promise for treating ADHD, compared to cannabis that contains THC and CBD. Talk to your healthcare provider about your specific situation. 

    • Could microdosing cannabis help with ADHD symptoms?

      There’s not enough research to conclude whether cannabis helps people with ADHD. This includes microdosing, or the practice of taking ultra low doses of cannabis to help manage symptoms without a high. If you’re interested in microdosing to help control ADHD, talk with your healthcare provider.

  • VA gov won’t overturn legal cannabis, but sales unclear (Newsletter: January 4, 2022)

    VA gov won’t overturn legal cannabis, but sales unclear (Newsletter: January 4, 2022)

    RI leaders close to legalization deal; Bourbon-selling KY senator worried about medical marijuana; Record IL cannabis sales

    Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.

    Your support makes Marijuana Moment possible…

    Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there.

    Support our work at https://www.patreon.com/marijuanamoment

    / TOP THINGS TO KNOW

    The federal monopoly on growing cannabis for research has officially ended, with two companies telling Marijuana Moment that they’ve harvested their first Drug Enforcement Administration-approved crops in recent weeks.

    Rhode Island’s House speaker and Senate president indicated in opening remarks at the start of the legislative session that they are nearing a deal on how to regulate the marijuana industry in a new legalization bill expected to be filed this month. But Gov. Dan McKee (D) might not be on board with a key detail.

    Kentucky’s Senate majority floor leader—who owns a bourbon company called “Kentucky Senator”—said he opposes medical cannabis despite strong support from his constituents.

    • “If they don’t like it, they can take it out on me in the next election.”

    The Illinois Department of Financial and Professional Regulation reported that marijuana businesses set a sales record in December, closing out a year with nearly $1.4 billion worth of legal cannabis products sold—more than doubling 2020’s total.

    / FEDERAL

    Senate Majority Leader Chuck Schumer (D-NY) tweeted, “The War on Drugs has been a war on people—particularly people of color. I’m working to pass our bill to end the federal marijuana prohibition, enact criminal justice reforms, and ensure equity for those impacted by the War on Drugs.”

    Pennsylvania Democratic Senate candidate John Fetterman, currently the lieutenant governor, tweeted about a local move to reduce some marijuana charges, saying, “Lebanon 🔴  is one of Pennsylvania’s most conservative counties. I commend the DA for adopting these common sense changes to marijuana charges. Legalization is “inevitable” in PA. Those aren’t my words. They belong to a Republican state Senator.”

    Kentucky Democratic Senate candidate Charles Booker tweeted, “There is overwhelming bipartisan support to legalize medical cannabis in Kentucky. The politicians blocking it know that very well.”

    Texas Democratic congressional candidate Coy Branscum tweeted, “I support federal efforts to legalize adult use marijuana. This will be a boon for investment in our country and will provide much needed criminal justice reform for our country.”

    / STATES

    Mississippi’s lieutenant governor pushed back against Gov. Tate Reeves’s (R) criticism of pending medical cannabis legislation, while the House speaker said it is “not the top issue” for the session. Separately, a senator is proposing a medical marijuana bill that would ban smoking.

    Tennessee Democratic gubernatorial candidate Jason Martin tweeted that voters told him it’s a priority to work on “updating Tennessee’s antiquated marijuana laws.”

    The Louisiana legislature’s Industrial Hemp Advisory Committee met.

    An Indiana representative said he doesn’t think there’s enough support in the legislature to pass marijuana reform.

    A Wisconsin senator applauded Gov. Tony Evers (D) for pardoning people with marijuana convictions.

    Montana’s Supreme Court has been slow to set up a specialized court to handle marijuana expungements.

    Massachusetts’s top marijuana regulator said implementing delivery services can “take a big chunk out of” the illegal market.

    Virginia regulators are considering amending rules for marijuana field tests and are accepting comments on proposed changes to rules on medical cannabis product labeling and access to facilities.

    Illinois regulators are beginning rulemaking on changes to the medical cannabis program.

    The New York Department of Agriculture and Markets tweeted, “We’re proud to announce that our Hemp Program Plan has been approved by @USDA. All growers who were licensed under our former Industrial Hemp Agricultural Research Pilot Program need to reapply under this new program in order to grow hemp this year.”

    Colorado regulators gave an update on the marijuana program in the Department of Revenue’s annual report.

    Oklahoma regulators sent an update about a switch to new medical cannabis licensing software this month.

    The Idaho Global Entrepreneurial Mission reported on hemp projects it is funding.


    Marijuana Moment is already tracking more than 800 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

    Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.

    / LOCAL

    Portland, Oregon officials posted application materials for cannabis business emergency relief funds.

    Oakland, California’s Cannabis Regulatory Commission will meet on Thursday.

    / INTERNATIONAL

    Philippine President Rodrigo Duterte said he will “never, never apologise for the deaths” in his nation’s bloody “drug war.”

    London, England’s mayor clarified that a new arrest diversion plan will only apply to people under 25 and for marijuana only, not other drugs. A spokesperson for UK Prime Minister Boris Johnson reacted by saying that “illegal drugs destroy lives and fuel violence.” And the leader of the Labour Party said he’s “not in favour of changing the drugs laws.”

    Quebec, Canada’s government is denying access to marijuana and alcohol retail locations to people who have not received COVID vaccinations.

    / SCIENCE & HEALTH

    A study concluded that medical cannabis “use for chronic pain is increasing with cannabis legalization.”

    A study of mice suggested that “both cannabinoids and terpenes in oil extracts should be considered as potential therapeutic agents against epileptic seizures and epilepsy.”

    / ADVOCACY, OPINION & ANALYSIS

    The Kentucky Democratic Party tweeted, “Nine out of 10 Kentuckians support legalizing medical marijuana. Republicans in Frankfort aren’t representing Kentucky’s interests — just their own.”

    The Indiana Democratic Party tweeted, “A state that Donald Trump won by 16 points [Montana] made recreational cannabis legal. The @indgop’s opposition to marijuana is more out of touch with most of the larger @GOP. Their partisanship is harming Indiana’s economic potential.”

    The Association for Cannabis Health and Medicine will host a summit on cannabis in sports on January 22.

    / BUSINESS

    MJBiz was acquired by Emerald Holding, Inc.

    The Scotts Miracle-Gro Company acquired Luxx Lighting and True Liberty Bags.

    Trulieve Cannabis Corp. won a dismissal of a lawsuit that accused the company of misleading investors about the quality of its cultivation facilities.

    The Honeybee Collective raised a $107,000 funding round.

    / CULTURE

    David Crosby gave a reporter tips about how to roll a joint and spoke about his forthcoming cannabis brand.

    Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.

    Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

  • Medical cannabis holds promise to help people with inflammatory skin conditions

    Medical cannabis holds promise to help people with inflammatory skin conditions

    Persons with pores and skin situations are open to hoping professional medical hashish items as probable treatments in accordance to a analyze from the George Washington University University of Medication and Health Sciences and College of Maryland.

    People today with skin problems are open up to hoping clinical cannabis products and solutions as probable solutions, in accordance to a review from The George Washington College School of Medication and Wellbeing Sciences and the College of Maryland.

    The study, explained to be the biggest of its kind involving 504 respondents, uncovered that 88.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} help the use of medical hashish for dermatologic health conditions and several currently are carrying out so even with no advice from a dermatologist.

    Items out there in excess of-the-counter are hemp-derived and made up of CBD or cannabidiol they have extremely little or no THC. Each THC and CBD are naturally happening in hashish vegetation but CBD isn’t brain altering and won’t result in a large like THC.

    Practically 18{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of all those surveyed explained they use around-the-counter health care cannabis merchandise, or MCPs, in the variety of creams or oil-based mostly products and solutions to take care of ailments, these types of as acne breakouts, rosacea, atopic dermatitis and psoriasis.

    “Given that we know that consumers are currently employing hashish-dependent products with no a doctor’s recommendation, it is of the utmost worth that items out there above-the-counter have a sure amount of high-quality assurance,” stated Dr. Adam Friedman, professor and chair of dermatology at The George Washington College School of Drugs and Overall health Sciences in D.C.

    Friedman endorses individuals check a product’s business web site or request the statement of top quality assurance, which goes in excess of all the things from basic safety to probably even include things like facts about efficacy. He explained not getting capable to get a assertion of quality assurance ought to be a obvious indication not to use the merchandise.

    “The globe of health-related hashish is even now in its infancy, significantly of which is mainly because of all the restricted regulation and the unlawful designation of anything at all from the hashish plant,” Friedman said.

    He thinks that the potential should really be dazzling for MCPs since of what science is discovering about the human endocannabinoid program. It can be manipulated with cannabis to have incredible impact on inflammation and mobile turnover.

    “The endocannabinoid program regulates a lot of different biological procedures. It contains endocannabinoids, indicating cannabinoids, like discovered in the hashish plant that our bodies make that then bind to cannabis receptors to do a full range of things from sending indicators of agony and itch to regulating inflammation and even how cells make on their own,” he explained.

    “The long run is tremendously shiny for the translation of hashish to the bedside, in pretty much every self-control in drugs, the science is there. We now require the clinical study to verify what products will work on what,” Friedman claimed.

    Like WTOP on Facebook and abide by WTOP on Twitter and Instagram to have interaction in discussion about this post and many others.

    Get breaking news and day-to-day headlines sent to your email inbox by signing up listed here.

    © 2022 WTOP. All Rights Reserved. This website is not supposed for people positioned inside the European Economic Area.